Espressione dell'antigene carboidratico Lewis nei tumori umani.

Translated title of the contribution: Expression of Lewis carbohydrate antigen in human tumors

Vincenzo D'Alessandro, Daniela Terracciano, Enrico Di Salvo, Andrea Renda, Mario Luigi Santangelo, Angelina Di Carlo, Angela Mariano, Vincenzo Macchia

Research output: Contribution to journalArticlepeer-review


In this study we show, by immunoblotting, that Mab B3, a newly isolated monoclonal antibody, reacts with a variety of glycoproteins with different molecular weights expressed in gastric, pancreatic and colorectal cancers. The reactivity pattern differed in cancers arising in different tissues, though no correlation was observed with the histopathological characteristics of the lesions analysed. MAb B3 does not react with liver, brain or kidney cancers and has a limited reactivity with lung cancers but reacts very strongly with metastatic lesions. Because of the limited reactivity of this antibody with normal tissues, MAb B3 genetically fused with toxin in the form of a recombinant immunotoxin may be useful in treating certain kinds of cancer such as metastatic lesions. However, until current trials are completed, we will not know whether this immunotoxin will be helpful in cancer treatment.

Translated title of the contributionExpression of Lewis carbohydrate antigen in human tumors
Original languageItalian
Pages (from-to)355-361
Number of pages7
JournalChirurgia Italiana
Issue number3
Publication statusPublished - May 2002

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Expression of Lewis carbohydrate antigen in human tumors'. Together they form a unique fingerprint.

Cite this